AHA: PCSK9 Drug Lowers LDL Over Longer Term

Published December 3, 2013

AHA: PCSK9 Drug Lowers LDL Over Longer Term

Filed under: Drug Treatment Help Dallas

DALLAS — The anti-PCSK9 monoclonal antibody evolocumab maintained dramatically reduced cholesterol levels over 1 year, phase II trial extension studies showed. Mean reduction in LDL was 52.1% … "Ongoing outcomes trials will further define the …
Read more on MedPage Today

GlaxoSmithKline drug fails in late-stage study

Filed under: Drug Treatment Help Dallas

GlaxoSmithKline PLC, or GSK, said it will wait for results from a separate late-stage study before deciding what to do next with the drug. It acquired the experimental treatment when it bought longtime drug development partner Human Genome Sciences for …
Read more on WFAA

Rehab: Brown threw rock through mom's car window

Filed under: Drug Treatment Help Dallas

Superior Court Judge James Brandlin also added additional rules for Brown in the coming months, requiring him to perform at least 24 hours of community labor a week and to submit to drug testing as he deals with anger management issues. Brown and his …
Read more on FOX 4 News